Cost of Care for Diabetics in the U.S. Tripled in Past Decade
Insulin-dependent diabetics in the U.S. are unlikely to see relief from their high medication costs for diabetes any time soon. Data from researchers at the University of Michigan in Ann Arbor and the University of Melbourne in Australia have identified a triple increase in the cost of insulin over the past decade.
Both the yearly spending and the base cost per milliliter of insulin for diabetic patients has risen sharply over the past 10 years. In fact, the increase in cost became so drastic in 2010 that it surpassed the per-person spend on all other diabetes medications combined, according to the research published in JAMA.
In 2002 the yearly per-patient cost for insulin was $231 which increased to $736 in 2013. The cost per milliliter of insulin also rose at a similar rate, with a single ml costing $4.34 in 2002 and later $12.92 in 2013. Another issue with the cost increase is that insulin usage in diabetic patients is also on the rise. In 2002 the average amount of insulin used yearly rose from 171 ml to 206 ml in 2013.
Due to the regulation of insulin products, price competition from generic brands is unlikely, meaning the overall cost of insulin-based treatment is likely to continue to increase. Doctors are now looking at non-insulin treatment opportunities both for cost-effectiveness and health-effectiveness.
Financial Aid May Be Available for Diabetic Patients with Severe Complications
Diabetes is one of many health conditions that can cause other disabling conditions, such as neuropathy, and cause amputation. If your diabetes or any other related condition keeps you from working or earning a substantial income for you and your family, you may be eligible for Social Security disability benefits or financial assistance.
Contact the Disability Help Group at 800-800-2009 to schedule a consultation with our disability advocates!